CMOs Face Capacity Challenges, Talent Shortages As Pandemic Increases Demand For Their Services
Executive Summary
The need for more plant capacity, process scale-up and skilled workers are major challenges cited by a CMO in producing clinical trial materials for COVID-19 vaccines. Recent white paper says 70% of manufacturers expect to outsource activities due to pandemic.
You may also be interested in...
COVID-19 Spurs WHO To Revise Guidance On Technology Transfers
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Pfizer’s Expected 2020 COVID-19 Vaccine Production Fell By 50% After Scaleup Delays
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine
The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.